PHT signs 11 new trials in second-quarter 2010

PHT Corporation featured scientific education as a key focus during its record-breaking second fiscal quarter of 2010. PHT is the global innovator in ePRO (electronic patient reported outcome) and PRO (patient reported outcome) solutions that maximize clinical data management by incorporating the world's best digital diaries in eClinical trials.

“Clinical trial sponsors use PHT's ePRO System because only PHT offers a full range of proven ePRO options to suit every clinical trial. Sponsors know we lead the market because of our focus on sponsor satisfaction and constant innovation across our product offering to maximize value for customers.”

The company announced total bookings increased by 41% over the same fiscal period for 2009 and that it signed 11 new trials including three from new customers in the second quarter.

PHT's President and CEO Phil Lee said, "Clinical trial sponsors use PHT's ePRO System because only PHT offers a full range of proven ePRO options to suit every clinical trial. Sponsors know we lead the market because of our focus on sponsor satisfaction and constant innovation across our product offering to maximize value for customers."

Key highlights from PHT's record-breaking 2010 second quarter:

• 11 new trials including 3 new customers.
• Expanded headcount - PHT opened new requisitions in the areas of service delivery, software product development and testing, marketing and support, due to increased demand for PHT's services. The staff expansion of five percent will enable PHT to continue providing world-class, ISO-certified support for customers' current and scheduled clinical trials as it maintains its drive to innovate PRO and ePRO solutions.
• Strategic partnership with diabetes expert Entra Health Systems, Inc. - PHT and Entra Health Systems announced a strategic partnership that offers sponsors a combined glucose and data monitoring technology using Entra Health's MyGlucoHealth wireless meter and PHT's ePRO System to study diabetes and patient blood glucose levels.
• Integration educational series with partners Almac Clinical Technologies and Medidata Solutions - Almac, PHT, and Medidata met with biopharmaceutical companies to discuss the integration of eClinical data from study start to archive. Sponsors saw live demos of data streaming from Almac's randomization system to PHT's ePRO system to Medidata's EDC system.
• European PRO and ePRO Conference - PHT gathered more than 30 biopharmaceutical and life science experts at the PHT 2010 European PRO and ePRO Conference, the most comprehensive, educational event of its kind. The meeting featured PRO experts, global pharmaceutical case studies, and a distinguished keynote presentation by Mira Pavlovic of the European Medicines Agency, who offered an exclusive look at the global regulatory perspectives on outcomes measurements and validation requirements.
• Education and thought leadership - PHT representatives spoke at six major educational industry events where presenters informed audiences about innovative new capabilities and technology advances in the PHT ePRO System and future directions for the clinical trials industry. Additionally, PHT Director of Clinical Operations and Scientific Advisor Dr. Barbara Marino was named to PharmaVOICE Magazine's prestigious PharmaVOICE 100 for her ability to understand sponsors' clinical trial needs.
• Drug Information Association (DIA) - PHT's Chief Scientific and Quality Officer Steve Raymond, PhD., co-chaired the eClinical session track at the U.S. Annual DIA meeting in Washington D.C. PHT speakers discussed data integration advancements, the interpretation of patient data to better predict patient behavior, and advances in combining physiologic and subjective data for enhanced data analysis.